Article thumbnail

Metformin Attenuates The Exacerbation Of The Allergic Eosinophilic Inflammation In High Fat-diet-induced Obesity In Mice.

By Marina Ciarallo Calixto, Letícia Lintomen, Diana Majoli André, Luiz Osório Leiria, Danilo Ferreira, Camilo Lellis-Santos, Gabriel Forato Anhê, Silvana Bordin, Richardt Gama Landgraf and Edson Antunes


A positive relationship between obesity and asthma has been well documented. The AMP-activated protein kinase (AMPK) activator metformin reverses obesity-associated insulin resistance (IR) and inhibits different types of inflammatory responses. This study aimed to evaluate the effects of metformin on the exacerbation of allergic eosinophilic inflammation in obese mice. Male C57BL6/J mice were fed for 10 weeks with high-fat diet (HFD) to induce obesity. The cell infiltration and inflammatory markers in bronchoalveolar lavage (BAL) fluid and lung tissue were evaluated at 48 h after ovalbumin (OVA) challenge. HFD obese mice displayed peripheral IR that was fully reversed by metformin (300 mg/kg/day, two weeks). OVA-challenge resulted in higher influx of total cell and eosinophils in lung tissue of obese mice compared with lean group. As opposed, the cell number in BAL fluid of obese mice was reduced compared with lean group. Metformin significantly reduced the tissue eosinophil infiltration and prevented the reduction of cell counts in BAL fluid. In obese mice, greater levels of eotaxin, TNF-α and NOx, together with increased iNOS protein expression were observed, all of which were normalized by metformin. In addition, metformin nearly abrogated the binding of NF-κB subunit p65 to the iNOS promoter gene in lung tissue of obese mice. Lower levels of phosphorylated AMPK and its downstream target acetyl CoA carboxylase (ACC) were found in lung tissue of obese mice, which were restored by metformin. In separate experiments, the selective iNOS inhibitor aminoguanidine (20 mg/kg, 3 weeks) and the anti-TNF-α mAb (2 mg/kg) significantly attenuated the aggravation of eosinophilic inflammation in obese mice. In conclusion, metformin inhibits the TNF-α-induced inflammatory signaling and NF-κB-mediated iNOS expression in lung tissue of obese mice. Metformin may be a good pharmacological strategy to control the asthma exacerbation in obese individuals

Topics: Amp-activated Protein Kinases, Animals, Asthma, Blotting, Western, Bronchoalveolar Lavage Fluid, Diet, High-fat, Enzyme Inhibitors, Eosinophils, Guanidines, Hypoglycemic Agents, Inflammation, Insulin Resistance, Lung, Male, Metformin, Mice, Mice, Inbred C57bl, Nitric Oxide, Nitric Oxide Synthase Type Ii, Obesity, Ovalbumin, Promoter Regions, Genetic, Protein Binding, Transcription Factor Rela, Tumor Necrosis Factor-alpha
Year: 2015
DOI identifier: 10.1371/journal.pone.0076786
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.